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ABSTRACT
Consumer Driven Health Plans (CDHPs) have been identified as a high-deductible insurance option that has
increased consumer responsibility while health care expenditures have decreased. Anticipated savings through the
use of CDHPs have drawn increased interest of employers and policymakers. The increased need to control
healthcare costs as well as healthcare utilization have also fostered the development of increased use of CDHPs. As
the use of CDHPs have expanded, educated consumers have become more engaged in their healthcare services and
have increased demands for transparency of healthcare costs. Healthcare costs, utilization, and moral hazard of
this study are further discussed.
Keywords: Consumer driven health plans, consumer engagement, cost, financial savings, healthcare spending,
moral hazard, transparency

INTRODUCTION
Consumer Driven Health Plans (CDHPs) are a type of high-deductible health plan with lower premium
rates paired with higher minimum deductibles and higher out-of-pocket limits (Lo Sasso, Shah, & Frogner,
2010). CDHPs were first introduced to the United States (U.S.) through e-commerce ventures in the late 1990’s
(Parente, 2006). CDHPs have been described as a three-tier payment system for health insurance comprised of a
savings account, out-of-pocket payments, and an insurance plan. (Yi, 2010). This three-tier system consists of: Tier
1) pre-tax dollars being invested into a health savings account (HSA) contributed by the enrollee or their employer
which is used for insurance plan deductibles, Tier 2) the coverage gap between current amount in an individual's
pre-tax account and the deductible with the insured being responsible for any amount not covered, Tier 3) when
health care expenses surmounts the deductible, then the high-deductible health insurance plan becomes a more
traditional health insurance plan with the insured paying a coinsurance amount for benefits until an out-of-pocket
maximum is met (Yi, 2010). CDHPs have gained popularity: due to the need to create conscientious consumers
who are informed users of healthcare while also reducing utilization has made CDHPs appealing to insurance
companies as well as employers (Hibbard, Greene, & Tusler, 2008).
The original purpose of CDHPs were to decrease the rising cost of health insurance, premiums increased
73% over a period of 5 years, that employers were responsible for by making the consumer have a higher level of
cost sharing and increased their awareness of their healthcare spending (Fronstin & Collins, 2005; Jordan,
2016). CDHPs have continued to hold the attention of policymakers, employers, as well as consumers due to the
potential of decreased health care costs; those enrolled in a CDHP spent 6%-9% less than those enrolled in a
traditional health care plan (Lo Sasso, et al., 2010). Consumer engagement through the use of pre-taxed savings
accounts such as Health Reimbursement Accounts, HSA, Flexible Spending Accounts, and high-deductible
insurance policies have reduced expenditures for employers, estimates are 20%-25% savings for employers (Buntin
et al., 2006; Davis, 2008). When consumers planned and coordinated funds allotted to them for their health care
services, deductibles for a single person were $1,050 and deductibles for a family were more than $2,700, they were
exposed to the financial responsibilities of their healthcare expenditures (Jordan, 2016; Leung & Escarce, 2017, Lo
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Sasso, et al., 2010). Kavanagh (2007) found that the estimated costs for a family who participated in a CDHP was
$11,000 per year.
Enrollment in high-deductible health plans has increased from 26.3% in 2011 to almost 40% in 2016
compared to only 4% in 2006 (Claxton, et al., 2008; Cohen & Zammitti, 2016). The leading proponents in this
increase in CDHPs have attributed to providing the consumers more control of their health care spending and
effectively could be considered more control of their overall health care needs (Barry, Cullen, Galusha, Slade, &
Busch, 2008). Buntin et al. (2006) found that CDHPs were associated with lower costs of health care, estimates of
10%-25% savings, yet the effects on quality were mixed and a need for evidence regarding prices, treatment
choices, and quality was identified.
The debate over the efficiency of CDHPs has been controversial with proponents of CDHPs insisting that
consumers were able to make more cost-effective decisions, while critics of CDHPs have stated that higher cost
sharing would force enrollees to forgo needed medical treatment resulting in worse health outcomes and thus
increase in healthcare expenditures (Greene, Hibbard, Murray, Teutsch, & Berger, 2008). A 2005 survey performed
by the Employee Benefit Research Institute found that those enrolled in CDHPs were less satisfied with their health
plan compared to those in a comprehensive health plan, CDHPs created higher-out of pocket costs---31% of those
participating in a CDHP spent 5% or more of their income on health care, and those enrolled in a CDHP were more
likely to avoid, skip, or delay medical care (Fronstin & Collins, 2005).
Lack of transparency has been described as a major issue for the consumers of healthcare in the U.S.
(Betbeze, 2016). CDHPs have been touted as bringing a revolution to transparency in healthcare (Hilsenrath, Eakin,
and Fischer, 2015). Transparency can be described as the results of the cost and quality of healthcare being delivered
with this information accessible to be used by the consumer for an informed decision (Wetzell, 2014). According to
Collins (2006), transparency of cost and quality of care have improved healthcare by three key reasons: 1) it has
helped providers improve their benchmarking of performance against other providers, 2) it has encouraged private
insurers and public programs to have a higher importance in quality and efficiency, and 3) it has allowed patients to
make informed choices about their care. Improved transparency has also benefitted employers by informing their
public policy agenda, supported improved benefit design strategies, stimulated competition based on value of health
plans, and advanced provider payment reform (Wetzell, 2014).
An argument against CDHPs has been that it would dramatically decrease the moral hazard of the
consumer resulting in the consumer not seeking medical care when necessary (Dixon, Greene, Hibbard,
2008). Moral hazard can be described as the shift in economic behavior when individuals are protected or insured
against risks and losses because another party is carrying all of the responsibility of the behaviors (Mendoza,
2016). In the healthcare arena, moral hazard has been typically shifted from the consumer to the insurer or provider,
but with CDHPs it has been hypothesized that all of the burden of cost has fallen upon the consumer thus decreasing
consumer moral hazard and patients would no longer seek medical direction in fear of cost (Geyman, 2007).
The purpose of this research study was to determine if CDHPs have created financial savings by increasing
transparency of healthcare cost and decreasing moral hazard.
METHODOLOGY
The hypothesis of this research was the use of CDHPs have increased financial savings to the consumer by
increasing transparency of cost in healthcare.
The methodology for this study was a literature review. Electronic databases used included Ebscohost,
CINAHL, Academic Search Premier, Alt HealthWatch, Health Source: Consumer Edition, Health Source:
Nursing/Academic Edition, MEDLINE, and Primary Search which were provided by Marshall University’s online
library. Google search engine as well as Google Scholar were also exhausted in a search using keywords when
articles could not be located from previously mentioned databases. Key words employed for literature recovery
included “consumer driven health plans” or “consumer engagement” and “financial savings” and “cost” or
“transparency” or “health spending” or “moral hazard”. Research results were limited to articles written in the
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English language and published between 2005 to 2018. A total of 34 resources were selected for this research after
a review of content deemed them relevant; 11 of these were utilized in the results of this study. The literature search
was performed by CF, CM, JM, and BW with validation by AC who also acted as a second reader and verified
literature met inclusion criteria.
RESULTS
Expenditures and Utilization
According to Bundorf (2016), CDHPs have reduced total yearly health care expenditures by approximately
5%–15% compared to similar plans consisting of lower deductibles and no health spending accounts. A study by
Frost and Kennedy (2016), found that the CDHPs population spent $659 less overall than the non-CDHPs
population; yet CDHPs population had a higher out-of-pocket cost, $1,030 for CDHPs compared to $687 for nonCDHPs as depicted by Figure 1. Figure 1 illustrates the average spending of different health care plans over a
period of five years.

Figure 1. 2010-2014 Average Annual Total Spending Per Capita, Out-of-Pocket Spending Per Capita, and Share of
Cost, by Plan Type

Source: Frost, A., & Kennedy, K. (2016)

Additionally, it was found that increasing the market share of employer-sponsored CDHPs to 50% from the
current level of 13% had the potential to reduce health care spending by about $57 billion annually (Haviland,
Marquis, McDevitt, & Sood, 2012). A decrease of this magnitude would be the equivalent of a four percent
reduction in total health care spending for the consumers under the age of 65 (Haviland, et al., 2012).
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Prior statements regarding enrollees underutilizing healthcare have proven to be debatable. An analysis by
Rowe, Brown-Steenson, Downey, and Newhouse (2008) found that when comparing CDHPs and preferred provider
organizations (PPOs) those enrolled in a CDHP utilized preventative services 29.1% compared to those engaged in
PPOs utilized the same services 23.8% which is depicted in Table 1. Table 1 depicts preventative care utilization of
a CDHP population versus a PPO.

Table 1. Preventive Care Visits Per Thousand Members Per Year, Nonelderly Health Reimbursement Arrangement
(HRA) And Preferred Provider Organization (PPO) Enrollees, 2003–2005
HRA (n=17,411) PPO (n=128,444)
2003

315

260

2004

280

228

2005

279

226

Source: Rowe, J. W., Brown-Stevenson, T., Downey, R. L., & Newhouse, J. P. (2008)

While the study performed by Rowe, et al. (2008) found that CDHP participants utilized preventative care;
in juxtaposition, a survey performed by Reed, Graetz, Fung, Newhouse, and Hsu (2012) found that enrollees with
CDHPs, fewer than one in five understood they were exempt from the cost of preventive care visits and medical
tests.
Medicine price information mechanisms, such as medicine objectives, target audiences, sources, and
volumes, have been directly related to the need for increased medicine price transparency (Hinsch, Kaddar, and
Schmitt, 2014). In a retrospective insurance claim analysis performed by Parente, Feldman, and Chen (2008) from
an employer that offered CDHPs, a Point of Service (POS), and a PPO plan, the CDHP pharmaceutical expenditure
was $240 lower than those in the PPO plan thus it created a cost neutral or cost saving to the employer and
consumer.
Transparency
The cost sharing associated with high-deductible health plans has placed increased attention on the lack of
transparency in the U.S. healthcare system (Winfield, 2018). Health Care Organizations (HCO) have been able to
position and fight for their consumers when greater transparency was available thus decreasing the cost to the
consumer while increasing quality of care (Winfield, 2018). Charge transparency interventions displayed to
physicians alone modified their ordering practices and prescribing behaviors (Goetz, Rotman, Hartoularos, and
Bishop, 2015). When residents were exposed to the transparent cost of tests, they were found to spend less;
disclosed price $1,297 versus undisclosed price of $2,205 (Goetz, et al., 2015). HCOs have become more
transparent through CDHPs which have made pharmaceutical sales more transparent as well, thus decreasing cost.
According to Goetz, et al. (2015) when medication choices were displayed with the price, physicians trended to
choose generic medication options to reduce cost and the use of expensive antibiotics dropped from 38% to 18%.
According to a study performed by Wilson, et al. (2009), the potential for increased financial responsibility
in CDHPs did not deter the consumer in pursuing necessary care when compared to a comprehensive major medical
plan (CMM). Furthermore, Wilson et al. (2009), found through Healthcare Effectiveness Data and Information Set
enrollees in CDHPs received higher quality of care than CMM enrollees related to lower back pain and better than
or equal care when consumers had chronic conditions. The CDHPs population were responsible for 24% of
healthcare costs compared to 14% for the non-CDHP population (Frost & Kennedy, 2016). Westover, Arredondo,
Chapa, Cole, and Campbell (2014) found that when CDHPs were offered to uninsured, non-Medicaid eligible adults
with incomes under 200% of the federal poverty line and compared that to a consumer with a Medicaid plan or
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commercially insured health plan that the cost sharing aspect of CDHPs did not sway the low-income CDHP
enrollee from seeking or receiving appropriate medical care.
The majority of CDHP enrollees tended to portray a higher education level, especially regarding their
health status and wellbeing (Bundorf, 2016). As a result, CDHP participants frequently utilized their healthcare
coverage frequently, properly, and efficiently (Bundorf, 2016). This researcher found CDHPs enrollment and
utilization to be directly proportional to income level and education level.
DISCUSSION
The purpose of this literature review was to determine if CDHPs had an effect on transparency in
healthcare, created financial savings, and affected the moral hazard of the consumer. The results of this research
indicated that CDHPs created an improved price transparency in healthcare as well as decreased health care
expenditures. The outcome of this literature review supported the use of CDHPs in an effort to control healthcare
expenditures and utilization.
Limitations
This literature review was limited by the data available for research, databases used, as well as research
bias of the studies selected for review. Limited quantitative data was found regarding consumer healthcare
premiums and out-of-pocket spending for consumers; and it was noted that the quantitative data utilized may have
been skewed by confounding factors. Minimal data was found regarding transparent healthcare cost and consumer
cost sharing.
Implications
Healthcare expenditures in the U.S. have skyrocketed to exponential amounts, in 1990 the gross domestic
product of healthcare was 5.98 billion dollars and rose to 18.03 billion dollars in 2015 (CDC, 2016), and efforts
made by the U.S. government to control these costs have been futile or only slightly effective. However, the
utilization of CDHPs has been an effective solution for cost control as well as appropriate utilization. CDHPs have
placed an increased amount of responsibility on the healthcare consumer and the result has been the creation of more
conscientious users of healthcare. Increased responsibility has created a beneficial effect on utilization of healthcare
services as well as transparency of healthcare costs; while not deterring the healthcare consumer from accessing care
when needed. As consumers of CDHPs have been burdened with a larger portion of their healthcare costs initially,
they have increased the demand for transparency in the cost of healthcare services.
The research conducted showed the demand for increased transparency had an effect on how physicians
created treatment plans for their patients. As prices were revealed, physicians were less likely to order unnecessary
medical tests and procedures; and patients were more likely to question the need for these services.
It was noted that those who participated in CDHPs were more conscientious users of healthcare. CDHPs
encouraged an appropriate use of healthcare services, thus decreasing over utilization of unnecessary healthcare
benefits. The necessity to make diligent decisions regarding healthcare forced participants to become better
educated regarding healthcare needs. As participants were better informed, they sought out cost effective services.
Even though concerns regarding the underutilization of healthcare services were noted, participants in CDHPs were
identified as being higher users of preventative services compared to those in other healthcare models. The use of
preventive healthcare services has been linked to healthier consumers and decreased healthcare cost (CDC, 2017).
Recommendations
CDHPs have been a valid alternative healthcare model for those who were willing to be educated,
conscientious consumers. CDHPs have allowed consumers to have greater control of their healthcare services
through negotiations and price transparency, but this model has not been identified as a feasible option for all
consumers. According to the results, there have been conflicting reports on consumer satisfaction of CDHPs. This
has been attributed to how the consumer utilized CDHPs. When a consumer utilized HSA and assessed cost
comparison of services, CDHPs were an appropriate insurance option. If the consumer failed to save for HSA and
used healthcare services frivolously, then CDHPs were not appropriate for that consumer.
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CONCLUSION
When healthcare consumers chose CDHPs they experienced decreased healthcare costs and improved
transparency in healthcare. Participants in CDHPs were more educated, conscientious users of healthcare than
participants in other health plan models. This literature review did support the hypothesis of these researchers; yet
in order to make a better-informed conclusion, more recent quantitative studies should be performed with
concentration placed on the use of preventative services, consumer cost sharing expenses, and transparency of
healthcare prices.
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